We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Peter Marks Testifies About Updating Vaccines to Address COVID-19 Variants
FDA’s Peter Marks Testifies About Updating Vaccines to Address COVID-19 Variants
Top U.S. health officials, including an FDA regulator testified on Capitol Hill this week that real-world evidence from people vaccinated against COVID-19 and data from ongoing trials will be used to decide how vaccines should be updated to handle variant strains.